A Cancer Research United Kingdom spokeswoman told AFP that around 9,000 patients in the United Kingdom will be recruited, while 2,000 in India will be involved in an anti-cancer trial, which is anticipated to open in 2016.

Researchers planned to separate patients into three different groups: one-third of the participants will be given 100 mg tablets, one-third will receive a 300 mg aspirin tablet each day, while the remaining will receive a placebo.

For past so many years, a lot of debates have been going on with regard to anti-cancer qualities of aspirin. All scientists are hoping that the drug should work as an alternative for cancer treatment and if it happens, it would not be wrong to say that it would be a game changer.

It is a beneficial deal as patients will get a chance to have cost effective way to treat the disease.

Ruth Langley, chief investigator from the MRC Clinical Trials Unit at the University College of London (UCL), commented on the trial “There's been a few interesting research suggesting that aspirin could delay or stop early stage cancers from coming back, but there's been no randomised trial to give clear proof”.

As you know everything has its pros and cons, so taking aspirin everyday has hazardous health issues as it can cause various side effects, such as bleeding from the stomach, or even the brain and ulcers.

In accordance with previous studies, it has already proved that aspirin is effective for heart attacks and strokes in a number of people, and a few further studies have also recommended that it can also avert some types of cancers.